Ryan Specialty (RYAN) Expected to Announce Earnings on Thursday

Ryan Specialty (NYSE:RYAN) is expected to release its earnings data after the market closes on Thursday, February 20th. Analysts expect Ryan Specialty to post earnings of $0.47 per share and revenue of $658.80 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Ryan Specialty Price Performance

Shares of RYAN opened at $67.10 on Thursday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The stock has a 50 day simple moving average of $65.70 and a 200 day simple moving average of $67.03. Ryan Specialty has a 52-week low of $43.26 and a 52-week high of $75.97. The firm has a market capitalization of $17.57 billion, a PE ratio of 87.14, a P/E/G ratio of 1.19 and a beta of 0.72.

Insider Activity

In other news, Director David P. Bolger sold 7,055 shares of the stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the sale, the director now directly owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. This represents a 8.28 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $67.39, for a total value of $2,358,650.00. Following the completion of the sale, the director now directly owns 65,100 shares in the company, valued at $4,387,089. This trade represents a 34.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 323,506 shares of company stock valued at $21,407,851. 11.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on RYAN. Wells Fargo & Company decreased their price objective on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 14th. Keefe, Bruyette & Woods decreased their price objective on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a research report on Friday, January 10th. Barclays boosted their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. Finally, Morgan Stanley began coverage on Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target for the company. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Ryan Specialty currently has an average rating of “Hold” and an average target price of $74.40.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.